MP

Manjulata Patel

Active Director Director DIN 10135267
DIN 10135267 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Manjulata Patel

Data last updated:

Manjulata Patel is a Director at Njs Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Njs Pharmaceutical Private Limited reported revenue of ₹4.4 Lakh (FY 2025).

DIN 10135267
Primary Designation Director
Industry Pharma
First Appointment 26 Apr 2023
Oldest Company Age 3 yrs
Largest company Njs Pharmaceutical Private Limited · ₹4.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Njs Pharmaceutical Private Limited U46497MP2023PTC065471
Director26 Apr 20232023₹4.4 Lakh (FY 2025)Active

Board colleagues of Manjulata Patel

NameDINCompanyDesignation
Roshni Yadav10135265Njs Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Njs Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Manjulata Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjulata Patel

Manjulata Patel currently holds 1 directorship: Njs Pharmaceutical Private Limited (Director, since 26 Apr 2023, revenue ₹4.4 Lakh (FY 2025)).

Manjulata Patel was first appointed on 26 Apr 2023 as Director at Njs Pharmaceutical Private Limited.

The current boards of Manjulata Patel's companies include Roshni Yadav (Njs Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available